News | Proton Therapy | May 19, 2016

Hong Kong Sanatorium & Hospital Selects Hitachi’s Proton Beam Therapy System

Hong Kong’s first proton therapy center is scheduled to treat patients by 2020

Hitachi, proton beam therapy, Hon Kong Sanatorium & Hospital, HSKH

May 19, 2016 — Hitachi Ltd. announced that Hong Kong Sanatorium & Hospital (HKSH) has selected Hitachi to supply a two-treatment gantry proton beam therapy (PBT) system, the first in Hong Kong Special Administrative Region.

The system will be provided through Hitachi’s subsidiary company, Million Hope International Limited (MHI). The order includes a 10-year contract for service and maintenance.

The PBT system will be installed in HKSH Eastern District Advanced Medical Centre, where the synchrotron-based accelerator has been positioned above the two treatment rooms in a space-saving, vertically-stacked design, ideal for tight, urban areas such as Hong Kong. The treatment rooms will be equipped with rotating gantries capable of treating patients with Hitachi’s Spot Scanning technology and is expected to be operational by 2020, marking Hitachi’s first PBT system order in Hong Kong.

Established in 1922, HKSH is a leading private hospital in a city well-known for the quality of its healthcare and is ranked among the best hospitals in Asia. It leads in advanced medical technologies, nursing care (with the oldest nursing school in the city), and patient-centric care, often regarded as the model of care within China. The new Advanced Medical Centre is part of HKSH’s expansion in eastern Hong Kong Island, consists of a 17-story clinical building on top of Hitachi’s underground PBT facility.

In December 2007, Hitachi cleared U.S. Food and Drug Administration (FDA) Premarket Notification Special 510(k) for spot scanning irradiation technology. The company proceeded to build advanced proton systems for MD Anderson Cancer Center (May 2008), Nagoya Proton Therapy Center (September 2013) and for the Hokkaido University Hospital Proton Beam Therapy Center (March 2014). In fiscal year 2015, three additional centers have also begun treatments in the United States.

Wyman LI, manager administration of Hong Kong Sanatorium & Hospital and chief operation officer of Million Hope International Limited, stated, “Our new facility will now be capable of one of the most advanced forms of cancer treatment, the first in Hong Kong. The Hitachi system, already in operation at world-class centers in Japan and in the United States, will allow us to provide highly sophisticated and effective treatment that has been previously unavailable in this region.”

Spot-scanning irradiation technology does not scatter proton beams as with conventional proton beam therapy. Rather, it repeatedly turns a narrow proton beam on and off at high speed as it progressively changes location to irradiate entire tumor volumes. Protons can be aimed with high precision according to the targeted tumors, even those with complex shapes, while minimizing the impact on nearby healthy tissue. Furthermore, customized equipment such as collimators and boluses are not required.

For more information: www.hitachimed.com

Related Content

Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients
News | Lung Cancer | September 18, 2019
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...
IBA Gathers Experts on Flash Irradiation During ASTRO
News | Proton Therapy | September 17, 2019
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019...
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Radiation Therapy | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of...
Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

News | Quality Assurance (QA) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning

The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning. Image courtesy of Siemens Healthineers.

News | Computed Tomography (CT) | September 15, 2019
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
Akesis Galaxy SRS System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | September 13, 2019
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has...
Philips Showcases Integrated Radiation Oncology Portfolio at ASTRO 2019
News | Radiation Oncology | September 13, 2019
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO...